Prenetics Global Limited has announced the launch of a corporate Bitcoin treasury strategy with an initial purchase of $20 million worth of Bitcoin. According to the company, it acquired 187.42 BTC at an average price of $106,712 per coin. Prenetics also said that its board has approved allocating the majority of its $117 million balance sheet to Bitcoin, a decision that puts the company among the most aggressive corporate adopters of BTC in the healthcare space.
The announcement is especially notable because Prenetics is a health sciences company rather than a crypto-native, financial, or mining business. In recent years, Bitcoin treasury strategies have usually been associated with software firms, investment vehicles, or companies directly tied to digital assets. Prenetics expands that narrative into the healthcare sector, suggesting that corporate Bitcoin adoption is moving beyond its earlier industry strongholds.
This strategic move follows the company’s transfer of ownership of ACT Genomics, a transaction that increased Prenetics’ pro-forma cash position to approximately $66 million. When combined with BTC holdings and short-term assets, total liquid assets now stand at around $117 million. That stronger balance sheet appears to be the foundation for the company’s more ambitious treasury allocation plans.
In a press release sent to Bitcoin Magazine, CEO Danny Yeung said the company’s strengthened balance sheet of cash, BTC, and short-term assets gives Prenetics the financial base to pioneer innovative treasury management approaches, including what he described as a historic Bitcoin treasury strategy. His comments framed the move not as a symbolic purchase, but as a core part of the company’s future capital allocation framework.
Why Prenetics Is Moving Into Bitcoin Now
The timing of the decision is closely tied to the company’s improved financial position. By strengthening its liquidity profile after the ACT Genomics ownership transfer, Prenetics gained more flexibility in how it manages capital on its balance sheet. Rather than leaving the majority of its liquid resources in conventional instruments, the company has chosen to make Bitcoin a central treasury asset.
That is a meaningful distinction. Some public companies make small Bitcoin purchases to test market reaction or signal openness to digital assets. Prenetics is presenting a much broader commitment. The board did not merely approve a one-off purchase; it approved the allocation of the majority of the company’s $117 million balance sheet to Bitcoin. That language indicates a strategic shift, not a minor diversification exercise.
Danny Yeung also stressed that this is not a short-term trade and not an attempt to time the market. He said Prenetics is implementing a comprehensive, long-term Bitcoin strategy that it believes can fundamentally transform the company’s value proposition. In other words, management appears to see Bitcoin not only as a reserve asset, but as a tool that could reshape how investors understand the company’s future.
Because Prenetics operates in health sciences, the move may attract attention from market participants who previously viewed Bitcoin treasury strategies as largely confined to technology or crypto-linked businesses. The implication is broader than one company’s purchase: Bitcoin is increasingly being evaluated as a corporate treasury asset across a wider set of industries.
Board Changes and Active Treasury Management
Alongside the Bitcoin purchase, Prenetics announced the appointment of Andy Cheung, former COO of cryptocurrency exchange OKEx, to its Board of Directors. This is a significant governance signal. It suggests the company wants seasoned digital asset expertise at the board level as it builds out its treasury framework.
Cheung said the company’s Bitcoin strategy will include active treasury management, using tools such as derivatives and structured products. He emphasized that the strategy is not about passively storing Bitcoin. Instead, Prenetics is looking at dynamic treasury management that includes derivatives, yield strategies, and institutional-grade trading techniques.
That approach differs from a simple buy-and-hold model. A passive treasury strategy mainly depends on Bitcoin appreciation over time. An active strategy, by contrast, may involve hedging exposure, seeking yield, managing liquidity more precisely, and optimizing returns under changing market conditions. Such a model can be more sophisticated, but it also requires stronger operational controls and experienced decision-makers.
For a company entering Bitcoin at this scale, treasury execution becomes almost as important as the original purchase. Volatility, accounting treatment, liquidity needs, and risk management all matter. By bringing in a former exchange executive with deep market experience, Prenetics is signaling that it wants to manage Bitcoin as a professional treasury asset rather than as a static balance-sheet experiment.
Institutional Partnerships, Advisors, and Bitcoin Payments
Prenetics said it plans to expand its Bitcoin holdings through institutional capital partnerships. The company also intends to implement advanced return strategies, indicating that it sees treasury management as an ongoing process rather than a completed transaction. While the announcement did not detail specific structures or products, the language points to a framework designed for continuous deployment and optimization of treasury capital.
The company also plans to accept Bitcoin payments across its direct-to-consumer platforms, including IM8 Health and CircleDNA. This is an important extension of the treasury strategy into the operating business. Once a firm begins accepting BTC as payment, Bitcoin is no longer only a reserve asset on the balance sheet; it also becomes part of customer interaction, settlement flows, and brand positioning.
That combination of treasury allocation and payment acceptance gives Prenetics a broader Bitcoin profile than many corporate adopters. Some firms buy BTC but never integrate it into day-to-day business functions. Prenetics is signaling that Bitcoin could play both a financial role and a commercial role inside the company.
In addition to Andy Cheung, Prenetics is working with two industry advisors. One is Tracy Hoyos Lopez, Chief of Staff at Kraken and a board member at the Bitcoin Advocacy Project. The other is Raphael Strauch, founder of crypto conference TOKEN2049. Together, these advisors add institutional market knowledge, policy and advocacy insight, and deep crypto ecosystem connections.
Financial Growth and the Broader Meaning for Bitcoin Adoption
Prenetics also highlighted strong recent business momentum. The company reported a 336.5% year-over-year revenue increase in Q1 2025. It now operates three consumer health brands and maintains a debt-free balance sheet. That context matters because it frames the Bitcoin decision as a proactive strategic move made from a position of strength, rather than a desperate attempt to change investor sentiment.
A debt-free balance sheet is particularly relevant in discussions about Bitcoin treasury strategies. When a company with limited leverage chooses to hold BTC, the market may view that decision differently from a highly indebted firm making a speculative bet. In Prenetics’ case, the message is that the company has enough financial flexibility to pursue a long-term Bitcoin policy without the immediate pressure of debt obligations.
Viewed together, the company’s actions form a multi-layered strategy: strengthen liquidity through the ACT Genomics transaction, deploy $20 million into 187.42 BTC, place an experienced crypto operator on the board, work with prominent advisors, explore derivatives and structured products, and prepare to accept Bitcoin payments through consumer-facing platforms. This is much more comprehensive than a headline about simply buying Bitcoin.
The broader significance lies in sector expansion. Bitcoin’s corporate adoption story has often centered on technology companies, crypto businesses, or financial market participants. Prenetics shows that the healthcare sector is now entering that conversation. The company’s strategy underscores Bitcoin’s continuing growth as a treasury asset, but this time the signal is coming from within healthcare rather than from a traditionally crypto-aligned industry.